Jobs / United States / Pfizer INC
Upstream Process Development Lead
Pfizer INC · 🇺🇸 United States - New York - Pearl River
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 40 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 9 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Pfizer INC
The US Department of Labor certified 40 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 9 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Pfizer INC →
About the role
ROLE SUMMARY This laboratory-based leadership role will lead upstream process development for both mammalian cell culture and microbial fermentation platforms within Vaccines Early Bioprocess Development (EBPD). The incumbent will provide scientific and people leadership for the design, planning, execution, and interpretation of experiments supporting recombinant protein and vaccine antigen production. The role requires strong expertise in upstream process development, including host and cell-line evaluation, media and feed optimization, bioreactor process development, and integration of product yield and quality considerations. The successful candidate is expected to bring deep expertise in at least one platform, mammalian cell culture or microbial fermentation, together with demonstrated knowledge of and ability to lead programs across the other platform. Responsibilities include application of high-throughput and scale-down models, Design of Experiments (DOE), process characterization and modeling, scale-up, technology transfer, and development of processes suitable for good manufacturing practice (GMP) manufacture. Experience with automated and conventional bioreactor systems, such as ambr, stirred-tank bioreactors, and rocking-motion bioreactors, is highly valued. The role requires rigorous documentation, clear communication of data and recommendations, effective cross-functional collaboration, and a proven record of scientific and team leadership. ROLE RESPONSIBILITIES · Provide scientific and people leadership for the upstream process development workstream spanning mammalian cell culture and microbial fermentation within the Vaccines EBPD Process Development group. · Lead the design, prioritization, execution, documentation, and communication of complex studies to improve cell growth, recombinant protein expression, product yield, and quality across mammalian and microbial production systems, using DOE and mechanistic modeling approaches where appropriate. · Direct the evaluation and optimization of production hosts or cell lines, inoculum and seed-train strategies, culture media and feeds, and bioreactor operating parameters. · Apply platform-appropriate strategies to mammalian cell culture and microbial fermentation while identifying opportunities for common workflows, high-throughput experimentation, automation, digital tools, and continuous improvement. · Provide scientific judgment and coaching to direct reports and collaborators. Translate experimental results into clear process development decisions, risk assessments, and recommendations. · Lead upstream scale-up and technology-transfer activities through effective cross-functional interfaces. Author or review development reports, process descriptions, and technology-transfer documentation. · Represent the Process Development group on project subteams and collaborate with colleagues across Vaccines EBPD and partner organizations to align plans, timelines, deliverables, and issue resolution. · Evaluate and implement new upstream technologies that strengthen mammalian cell culture and microbial fermentation capabilities. Maintain current knowledge through scientific literature, external meetings, and internal technical forums. Work a flexible schedule, including occasional work outside core hours or on weekends, when required to support time-sensitive experiments. QUALIFICATIONS Required: · PhD in biochemical or chemical engineering, microbiology, cell biology, biotechnology, biochemistry, or a related discipline with at least five years of relevant experience; or an MS/BS with at least 10 years of relevant experience appropriate to the position. · Demonstrated expertise in upstream bioprocess devel